the year ahead, what we expect:

Hi all

I have copied this straight from the recent JP Morgan Healthcare Conference presentation which is on MSB website:

?Commencement of Phase 3 trial for congestive heart failure involving an early interim analysis to evaluate evidence of efficacy
?Commencement of Phase 3 trial for lumbar spinal fusion
?Clinical results in Phase 2 trials with early type 2 diabetes and intervertebral disc repair
?Ongoing Phase 2 trial for AMI and Phase 3 for BMT
?Expand focus on intravenous product franchise with commencement of Phase 2 trials for
?diabetic kidney disease
?rheumatoid arthritis
?lung diseases
?Additional partnering opportunities – optimal timing

My question is, to any of you who might be aware, is what is the likely timeframe for results to be known and released to the market?
I have mentioned before i don't care about the short term sp swings, as i am awaiting the results of the above to determine the true value of MSB.
My hopes are raised that 2013 will deliver results, more-so positively naturally.